高级检索
    韩宝惠, 刘思阳. ⅠB~ⅢA期非小细胞肺癌患者厄洛替尼对比安慰剂辅助治疗的疗效比较[J]. 循证医学, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
    引用本文: 韩宝惠, 刘思阳. ⅠB~ⅢA期非小细胞肺癌患者厄洛替尼对比安慰剂辅助治疗的疗效比较[J]. 循证医学, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
    shu
    Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
    Citation: Reviewer: HAN Bao-hui, Literature Co-worker: LIU Si-yang. Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 222-225. DOI: 10.12019/j.issn.1671-5144.2018.04.008
    shu

    ⅠB~ⅢA期非小细胞肺癌患者厄洛替尼对比安慰剂辅助治疗的疗效比较

    Efficacy Comparison for Adjuvant Erlotinib Versus Placebo in Patients with StageⅠ B~ⅢA Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(7)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回